Log In
Print this Print this

Hypertension vaccine

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine targeting angiotensin II developed using AFFITOME technology
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Angiotensin II type 2 (AT2) receptor (ATGR2)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHypertension
Indication DetailsVaccinate against hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today